The agenda of the meeting is election of a new auditor for the Company. The Company's elected auditor, Contabile, has informed the Board that they do not have the capacity to continue their assignment responsibilities relating to the audit of the Company. Based on a tender process PricewaterhouseCoopers (PWC) is proposed by the Board to be elected as the Company's new auditor. PWC is considered to handle the Company's future plans for development and will offer good competence and availability. See attached notice for more information.  

Shareholders are encouraged to cast their votes in advance of the General Meeting or grant the Chair of the Board a proxy, with or without voting instructions.

Deadline for registration of attendance, advance votes, proxy or instructions is 15 November 2024 at 16:00 (CET). For attendance to the live event, please follow the instruction in the notice.

For further information, see the attached Notice of the Extraordinary General Meeting, which can also be accessed from the company's website (https://arctic-bioscience.com/investors/general-meetings/).

This information is subject to the disclosure requirements pursuant to section 5-12 of the Norwegian Securities Trading Act.